DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

You have access
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, Matt Truman, Paul Bird, Hedley Griffiths, Lynden Roberts, Kathleen Tymms and Geoff Littlejohn

The Journal of Rheumatology August 1 2020, 47 (8) 1174-1181; DOI: https://doi.org/10.3899/jrheum.190535
You have access
Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change
Taysir G. Mahmoud, Jie Huang, Michelle Frits, Christine Iannaccone, Vivian Bykerk, Clifton O. Bingham III, Michael Weinblatt and Nancy A. Shadick

The Journal of Rheumatology March 1 2020, 47 (3) 333-340; DOI: https://doi.org/10.3899/jrheum.181160
You have access
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback and Glen S. Hazlewood

The Journal of Rheumatology February 1 2020, 47 (2) 176-187; DOI: https://doi.org/10.3899/jrheum.181165
Open Access
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale
Laure Gossec, Vibeke Strand, Clare Proudfoot, Chieh-I Chen, Sophie Guillonneau, Toshio Kimura, Hubert van Hoogstraten, Erin Mangan and Matthew Reaney

The Journal of Rheumatology October 1 2019, 46 (10) 1259-1267; DOI: https://doi.org/10.3899/jrheum.180904
You have access
Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. Bingham III, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen and Susan J. Bartlett

The Journal of Rheumatology September 1 2019, 46 (9) 1168-1172; DOI: https://doi.org/10.3899/jrheum.181185
You have access
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials
Kathleen M. Andersen, Jonathan T.L. Cheah, Lyn March, Susan J. Bartlett, Dorcas Beaton, Clifton O. Bingham III, Peter M. Brooks, Robin Christensen, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maarten de Wit, Amylou C. Dueck, Susan M. Goodman, Shawna Grosskleg, Catherine L. Hill, Martin Howell, Sarah L. Mackie, Bethan Richards, Beverly Shea, Jasvinder A. Singh, Vibeke Strand, Peter Tugwell, George A. Wells and Lee S. Simon

The Journal of Rheumatology August 1 2019, 46 (8) 1053-1058; DOI: https://doi.org/10.3899/jrheum.181123
You have access
Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis
Jessica Widdifield, Michal Abrahamowicz, J. Michael Paterson, Anjie Huang, J. Carter Thorne, Janet E. Pope, Bindee Kuriya, Marie-Eve Beauchamp and Sasha Bernatsky

The Journal of Rheumatology May 1 2019, 46 (5) 467-474; DOI: https://doi.org/10.3899/jrheum.180427
You have access
Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis
Caroline McCulley, Patricia Katz, Laura Trupin, Edward H. Yelin and Jennifer L. Barton

The Journal of Rheumatology December 1 2018, 45 (12) 1636-1642; DOI: https://doi.org/10.3899/jrheum.171339
You have access
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register
Sytske Anne Bergstra, Cornelia F. Allaart, Sofia Ramiro, Arvind Chopra, Nimmisha Govind, Cândida Silva, Elizabeth A. Murphy and Robert B.M. Landewé

The Journal of Rheumatology October 1 2018, 45 (10) 1361-1366; DOI: https://doi.org/10.3899/jrheum.171176
You have access
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study
Vivien M. Hsu, Christopher P. Denton, Robyn T. Domsic, Daniel E. Furst, Maureen Rischmueller, Marina Stanislav, Virginia D. Steen, Jörg H.W. Distler, Shimon Korish, Alyse Cooper, Suktae Choi, Peter H. Schafer, Gerald Horan and Douglas R. Hough

The Journal of Rheumatology March 1 2018, 45 (3) 405-410; DOI: https://doi.org/10.3899/jrheum.161040

Main menu

User menu

Search

DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

Pages

Content

Resources

Subscribers

More